Riskpilot← Back to searchSign inGet full accessOBSERVE MEDICAL ApS
APSActiveCVR 32763162Amaliegade 6Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 20101 employeeswww.observemedical.com
Revenue 2024
DKK 1,6M
-44% vs 2023
EBITDA margin
-75.6%
-29% vs 2023
Equity ratio
-171.6%
Financial strength
Net profit 2024
DKK -1,6M
-22% vs 2023
| Revenue | DKK 1,6M | -44% |
| EBITDA | DKK -1,2M | -29% |
| Net profit | DKK -1,6M | -22% |
| Total assets | DKK 1,7M | -15% |
| Equity | DKK -2,9M | -115% |
| Employees | 1 | — |
Legal name
OBSERVE MEDICAL ApS
CVR number
32763162
Legal form
Anpartsselskab
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
26. januar 2010
Share capital
DKK 584.519
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udvikle apparat til digital monitoring of a patients urinproduktion og dermed beslægtet virksomhed.
Address
Amaliegade 6
Email
order@observemedical.com
Website
www.observemedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 333 | -53 | -99 | 2.767 | 1.560 |
| Staff expenses | -0 | -0 | -307 | -3.436 | -2.566 |
| EBITDA | 333 | -53 | -467 | -918 | -1.180 |
| Depreciation & amort. | -641 | -525 | -410 | -264 | -186 |
| EBIT | -308 | -577 | -877 | -1.182 | -1.366 |
| Net financials | 6.698 | -3 | -15 | -108 | -209 |
| Profit before tax | 6.390 | -581 | -892 | -1.290 | -1.575 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 6.390 | -581 | -892 | -1.290 | -1.575 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.414 | 911 | 888 | 2.019 | 1.718 |
| Equity | 1.389 | 808 | -84 | -1.374 | -2.949 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25 | 102 | 971 | 3.392 | 4.667 |
| Total debt | 25 | 102 | 971 | 3.392 | 4.667 |
EBITDA margin
-75.6%
This company
15.8%
Market median
-578% vs market
20202024
Equity ratio
-171.6%
This company
38.2%
Market median
-549% vs market
20202024
Return on equity
-157545300.0%
This company
18.4%
Market median
-856224557% vs market
20202024
Net profit margin
-101.0%
This company
8.1%
Market median
-1347% vs market
20202024
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
20202024
Debt / equity
1.58×
This company
0.62×
Market median
-155% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LA Founder | Founder | 2010 |
JM Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (6) | ||
PM Management | Management | 2010 – 2015 |
BO Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
TR Chief Executive Officer | Chief Executive Officer | 2016 – 2019 |
KG Chief Executive Officer | Chief Executive Officer | 2019 – 2019 |
BL Management | Management | 2015 – 2016 |
ME Chief Executive Officer | Chief Executive Officer | 2019 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Former (13) | ||
| Board of Directors | 2011 – 2015 | |
| Board of Directors | 2013 – 2015 | |
| Board of Directors | 2011 – 2014 | |
| Board of Directors | 2010 – 2011 | |
| Board of Directors | 2010 – 2010 | |
| Board of Directors | 2010 – 2010 | |
| Board of Directors | 2016 – 2019 | |
TÅ | Board of Directors | 2016 – 2020 |
| Chairman | 2010 – 2010 | |
| Chairman | 2013 – 2015 | |
| Board of Directors | 2014 – 2015 | |
| Chairman | 2020 – 2022 | |
| Chairman | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2020 | |
| Individual | 100% | 100% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OBSERVE MEDICAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lavin AB | Founder | 0 companies |
| Per Magnus Emmoth | Management | 0 companies |
| Björn Oskar Larsson | Chief Executive Officer | 0 companies |
| Tom Rönlund | Chief Executive Officer | 0 companies |
| Kathrine Gamborg Andreassen | Chief Executive Officer | 0 companies |
| Jørgen Mann Nielsen | Chief Executive Officer | 0 companies |
| Bjørn Lindholt | Management | 0 companies |
| Magnus Emmoth | Chief Executive Officer | 0 companies |
| Claes Wilhelm Wenthzel | Board of Directors | 0 companies |
| Jon Ingi Benediktsson | Board of Directors | 0 companies |
| Ulla Brockenhuus-Schack | Board of Directors | 0 companies |
| Terje Bakken | Chairman | 0 companies |
| Carsten Schou | Board of Directors | 0 companies |
| Bengt Mikael Charlez | Board of Directors | 0 companies |
| Anna-Karin Sofia Ström | Board of Directors | 0 companies |
| Magnus Emmoth | Board of Directors | 0 companies |
| Toril Ås | Board of Directors | 0 companies |
| Hans Jarl Rutger Arnhult | Chairman | 0 companies |
| Kurt Erling Birk | Chairman | 0 companies |
| Ulf Lennart Rosén | Board of Directors | 0 companies |
| Terje Bakken | Chairman | 0 companies |
| Per Arne Nygård | Chairman | 0 companies |